Trials / Unknown
UnknownNCT04243057
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Beijing Tsinghua Chang Gung Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, two-way, non-intervention study. the main purpose: Understand the current status of diagnosis and treatment of cholangiocarcinoma patients in China and observe the effect of different treatment options on patient recurrence and long-term survival Secondary purpose: 1. Exploring the actual clinical treatment situation and its compliance with the existing diagnosis and treatment of bile duct cancer 2. Exploring the establishment of clinical research standard fields and standards for diagnosis and treatment of bile duct cancer
Conditions
Timeline
- Start date
- 2019-08-30
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2020-01-27
- Last updated
- 2020-01-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04243057. Inclusion in this directory is not an endorsement.